China National Medicines (SHSE:600511) Net Interest Margin (Bank Only) %


SHSE:600511 China National Medicines Corp Ltd SHSE:600511
86 GF Score
Price ¥26.94
GF Value ¥32.74
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is China National Medicines Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

SHSE:600511
86GF Score
China National Medicines Corp Ltd SHSE:600511
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is China National Medicines (SHSE:600511) Overvalued in 2026?

Based on GuruFocus' analysis, China National Medicines stock appears to be undervalued. The current stock price of ¥26.94 is trading 17.7% below its estimated GF Value™ of ¥32.74. GuruFocus considers China National Medicines to be Modestly Undervalued.

Key valuation signals for SHSE:600511:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: ¥32.74 vs. price of ¥26.94 (17.7% below fair value)
  • GF Score™: 86/100 with 4 warning signs

No single metric tells the full story. See the SHSE:600511 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


China National Medicines Business Description

Address No. 8, Xibinhe Road, Floor 6-9, West Tower, 7th Floor, Yongdingmen, Dongcheng District, Beijing, CHN, 100077
China National Medicines Corp Ltd focuses on producing special drugs and high-end prescription drugs. Its main goal is to provide customers with professional medical services. The company conducts its operations through two primary segments. The Commercial segment is mainly engaged in the sale of pharmaceuticals. The Others segment focuses on pharmaceutical manufacturing and logistics operations.
86GF Score

Get the complete analysis for SHSE:600511

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥26.94
Price
¥32.74
GF Value